NEW YORK --(BUSINESS WIRE)--Jan. 31, 2024-- DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that its Board of Directors has approved a new share repurchase program pursuant to which DocGo may purchase up to $36
Jan 31, 2024
NEW YORK --(BUSINESS WIRE)--Jan. 10, 2024-- DocGo Inc. (“DocGo” or the “Company”) categorically rejects this purported assessment by Fuzzy Panda Research , an obscure short seller motivated solely by profit. Their so-called “research report” uses what appears to be old, public information to
Jan 10, 2024